Staidson (Beijing) Biopharmaceuticals Co (SZSE:300204) E10: ¥-0.11 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SZSE:300204 Staidson (Beijing) Biopharmaceuticals Co Ltd SZSE:300204
46 GF Score
Price ¥20.94
GF Value ¥4.34
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Staidson (Beijing) Biopharmaceuticals Co E10?

Staidson (Beijing) Biopharmaceuticals Co SZSE:300204 -0.43% 46 E10 is ¥-0.11 as of Jun. 2026. GuruFocus rates SZSE:300204 with a GF Score™ of 46/100 and a GF Value™ of ¥4.34 (Significantly Overvalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Staidson (Beijing) Biopharmaceuticals Co's adjusted earnings per share data for the three months ended in Jun. 2026 was ¥-0.060. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ¥-0.11 for the trailing ten years ended in Jun. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Staidson (Beijing) Biopharmaceuticals Co was -19.90% per year. The lowest was -39.70% per year. And the median was -29.80% per year.

As of today (2026-09-05), Staidson (Beijing) Biopharmaceuticals Co's current stock price is ¥20.94. Staidson (Beijing) Biopharmaceuticals Co's E10 for the quarter that ended in Jun. 2026 was ¥-0.11. Staidson (Beijing) Biopharmaceuticals Co's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of Staidson (Beijing) Biopharmaceuticals Co was 212.00. The lowest was 23.97. And the median was 50.08.


Staidson (Beijing) Biopharmaceuticals Co  (SZSE:300204) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of Staidson (Beijing) Biopharmaceuticals Co was 212.00. The lowest was 23.97. And the median was 50.08.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Staidson (Beijing) Biopharmaceuticals Co E10 Related Terms


Staidson (Beijing) Biopharmaceuticals Co E10 Historical Data

* Premium members only.

The historical data trend for Staidson (Beijing) Biopharmaceuticals Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Staidson (Beijing) Biopharmaceuticals Co E10 Chart

Staidson (Beijing) Biopharmaceuticals Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.26 0.19 0.07 0.00 -0.08

Staidson (Beijing) Biopharmaceuticals Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.04 -0.06 -0.08 -0.09 -0.11

SZSE:300204 vs VRTX, REGN, MRNA: E10 Comparison

For the Biotechnology subindustry, Staidson (Beijing) Biopharmaceuticals Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Staidson (Beijing) Biopharmaceuticals Co Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Staidson (Beijing) Biopharmaceuticals Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Staidson (Beijing) Biopharmaceuticals Co's Shiller PE Ratio falls into.


SZSE:300204
46GF Score
Staidson (Beijing) Biopharmaceuticals Co Ltd SZSE:300204
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Staidson (Beijing) Biopharmaceuticals Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Staidson (Beijing) Biopharmaceuticals Co's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.06/116.0564*116.0564
=-0.060

Current CPI (Jun. 2026) = 116.0564.

Staidson (Beijing) Biopharmaceuticals Co Quarterly Data

per share eps CPI Adj_EPS
201609 0.190 102.400 0.215
201612 0.110 102.600 0.124
201703 0.140 103.200 0.157
201706 0.160 103.100 0.180
201709 0.170 104.100 0.190
201712 0.080 104.500 0.089
201803 0.110 105.300 0.121
201806 0.090 104.900 0.100
201809 0.050 106.600 0.054
201812 0.030 106.500 0.033
201903 0.060 107.700 0.065
201906 0.010 107.700 0.011
201909 0.010 109.800 0.011
201912 -0.030 111.200 -0.031
202003 -0.050 112.300 -0.052
202006 -0.110 110.400 -0.116
202009 -0.050 111.700 -0.052
202012 -0.070 111.500 -0.073
202103 -0.040 112.662 -0.041
202106 -0.090 111.769 -0.093
202109 -0.140 112.215 -0.145
202112 -0.020 113.108 -0.021
202203 -0.050 114.335 -0.051
202206 -0.130 114.558 -0.132
202209 -0.150 115.339 -0.151
202212 -0.080 115.116 -0.081
202303 -0.100 115.116 -0.101
202306 -0.220 114.558 -0.223
202309 -0.070 115.339 -0.070
202312 -0.450 114.781 -0.455
202403 -0.010 115.227 -0.010
202406 0.000 114.781 0.000
202409 -0.012 115.785 -0.012
202412 -0.280 114.893 -0.283
202503 0.000 115.116 0.000
202506 -0.047 114.907 -0.047
202509 -0.010 115.471 -0.010
202512 -0.100 115.832 -0.100
202603 -0.020 116.303 -0.020
202606 -0.060 116.056 -0.060

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ¥-0.11 mean?
Staidson (Beijing) Biopharmaceuticals Co (SZSE:300204) has a E10 of ¥-0.11 as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Staidson (Beijing) Biopharmaceuticals Co and its competitors.
Is Staidson (Beijing) Biopharmaceuticals Co's E10 too high?
Staidson (Beijing) Biopharmaceuticals Co's current E10 is ¥-0.11. Overall, Staidson (Beijing) Biopharmaceuticals Co has a GF Score™ of 46/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Staidson (Beijing) Biopharmaceuticals Co's E10 compare to VRTX and REGN?
Staidson (Beijing) Biopharmaceuticals Co's E10 of ¥-0.11 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Staidson (Beijing) Biopharmaceuticals Co and its competitors. Staidson (Beijing) Biopharmaceuticals Co's current E10 is ¥-0.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Staidson (Beijing) Biopharmaceuticals Co stock overvalued right now?
Based on GuruFocus' analysis, Staidson (Beijing) Biopharmaceuticals Co (SZSE:300204) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥4.34, compared to a current price of ¥20.94 — trading 382.5% above its estimated fair value. The current E10 is ¥-0.11. Staidson (Beijing) Biopharmaceuticals Co's overall GF Score™ is 46/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Staidson (Beijing) Biopharmaceuticals Co (SZSE:300204), the current E10 is ¥-0.11 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Staidson (Beijing) Biopharmaceuticals Co (SZSE:300204) Overvalued in 2026?

Based on GuruFocus' analysis, Staidson (Beijing) Biopharmaceuticals Co stock appears to be overvalued. The current stock price of ¥20.94 is trading 382.5% above its estimated GF Value™ of ¥4.34. GuruFocus considers Staidson (Beijing) Biopharmaceuticals Co to be Significantly Overvalued.

Key valuation signals for SZSE:300204:

  • E10: ¥-0.11
  • GF Value™: ¥4.34 vs. price of ¥20.94 (382.5% above fair value)
  • GF Score™: 46/100 with 4 warning signs

No single metric tells the full story. See the SZSE:300204 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Staidson (Beijing) Biopharmaceuticals Co Business Description

Address Rongjing Dong Street, No 5 Beijing Economic and Technological Development Zone, Beijing, CHN, 100176
Staidson (Beijing) Biopharmaceuticals Co Ltd is a pharmaceutical company mainly engaged in the research, development, production, and sale of biological products in China. Its products include mouse nerve growth factor injection, intravenous compound polyethylene glycol electrolyte powder solution, gliclazide, nabumetone, and aspirin.
46GF Score

Get the complete analysis for SZSE:300204

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥20.94
Price
¥4.34
GF Value